MG
EW icon

Marex Group’s Edwards Lifesciences EW Stock Holding History

Marex Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$248K Sell
3,095
-1,047
-25% -$86.3K ﹤0.01% 838
2025
Q4 		$353K Sell
4,142
-1,655
-29% -$136K ﹤0.01% 656
2025
Q3 		$451K Sell
5,797
-264
-4% -$20.6K ﹤0.01% 516
2025
Q2 		$474K Buy
6,061
+1,579
+35% +$118K ﹤0.01% 381
2025
Q1 		$325K Sell
4,482
-328
-7% -$23.5K 0.01% 433
2024
Q4 		$356K Buy
+4,810
New +$337K 0.01% 418
2024
Q1 		– Sell
-3,176
Closed -$242K – 567
2023
Q4 		$242K Buy
+3,176
New +$221K 0.01% 431

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Marex Group's EW Position: Q1 2026 in Review

Marex Group reduced its Edwards Lifesciences (EW) stake by 25% in Q1 2026, selling an estimated $86.3K and leaving 3,095 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #838.

Marex Group first reported a position in EW in Q4 2023 and has held it in 7 quarters since. The position peaked at $474K in Q2 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Marex Group held 3,095 shares of Edwards Lifesciences worth $248K as of Q1 2026.
  • Marex Group sold 1,047 Edwards Lifesciences shares in Q1 2026, an estimated $86.3K.
  • Edwards Lifesciences made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #838 holding.
  • Marex Group first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 7 quarters since.
  • Marex Group's Edwards Lifesciences position peaked at $474K in Q2 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.